An Open Community of Geroscience Solvers

Establishing reliable biomarkers of aging for longevity interventions.

Our Call To Action:

The lack of standardized, clinically validated methods to accurately measure aging as well as the safety and efficacy of anti-aging interventions creates a bottleneck in translating longevity interventions into clinically viable therapeutics. Our mission is to establish consensus and standards for biomarkers of aging, advancing scientific understanding and ensuring the success of innovations and interventions worldwide.

Our Programs:

We achieve our mission through open science, global collaboration, and sharing of critical data, tools, and insights.

We bring together leading researchers and stakeholders in the geroscience field to build and publish consensus roadmaps and standards for the systematic development and validation of biomarkers of aging. Visit our Manuscripts page here to learn about our latest work.
A first-of-its-kind, open source library designed for the evaluation and unified validation of biomarkers of aging, and contains many curated and harmonized large, high-quality omics and health datasets. Visit our Biolearn page here to learn more.
Our Biomarkers of Aging Challenge stimulates innovation and collaboration in the development of next-generation biomarkers that are highly predictive of chronological age, mortality, and multi-morbidity. Visit our Challenge page here to learn more.
A longitudinal multi-modal deep-profiling study leverages community-based cohorts and state-of-the-art molecular and functional profiling to explore how aging affects us at molecular and functional levels, shedding light on the changes driving functional decline. Visit The Longevity Study’s page here to learn more.
Our 2-day, in-person Conference at the Joseph B. Martin Conference Center at Harvard Medical School in Boston, featuring cutting-edge academic science of biomarkers of aging as well as translational, clinical and regulatory aspects of biomarkers of aging featuring the world’s leading academic and industry scientists. Visit our 2025 Conference page here to learn more.

We are a global, collaborative community of geroscience experts.

From scholars and healthcare practitioners to longevity industry pioneers and regulatory leaders, together we are advancing the development, validation, and implementation of aging biomarkers through cutting-edge translational research.